Vitamin D3 boosts IBD treatment in new trial
NCT ID NCT04225819
First seen May 01, 2026 · Last updated May 01, 2026
Summary
This study tests whether adding vitamin D3 to standard anti-TNF therapy helps people with active Crohn's disease or ulcerative colitis feel better and have healthier gut bacteria. About 100 adults starting anti-TNF treatment will receive either vitamin D3 or a placebo for 14 weeks. Researchers will track symptoms, stool samples, and blood markers to see if vitamin D3 improves outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.